Free Trial

Daré Bioscience (DARE) Earnings Date, Estimates & Call Transcripts

Daré Bioscience logo
$2.90 0.00 (0.00%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.87 -0.03 (-1.17%)
As of 05/23/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Daré Bioscience Earnings Summary

Daré Bioscience announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.50, which beat the consensus estimate of -$0.63 by $0.13. Quarterly revenue was reported to be $0.03 million, below analysts' expectations of $0.60 million. With a trailing EPS of -$0.17, Daré Bioscience's earnings are expected to decrease next year, from ($0.49) to ($1.90) per share.

Upcoming Q2
Earnings Date
Aug. 11After Market ClosesEstimated
Consensus EPS
(May. 13)
-$0.63
Actual EPS
(May. 13)
-$0.50 Beat By $0.13
Actual Revenue
(May. 13)
$0.03M

Q1 2025 Earnings Resources

DARE Upcoming Earnings

Daré Bioscience's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules.

Get Daré Bioscience Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Daré Bioscience and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DARE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DARE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Daré Bioscience Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.68-$0.57-$0.63
Q2 20252-$0.48-$0.23-$0.36
Q3 20252-$0.48-$0.45-$0.47
Q4 20252-$0.57-$0.21-$0.39

Daré Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2025
(Estimated)
--------
5/13/2025Q1 2025-$0.63-$0.50+$0.13-$0.50$0.60M$0.03M
3/31/2025Q4 2024-$0.66-$0.64+$0.02-$0.64$1.00M-$0.06M
8/12/2024Q2 2024-$0.57$1.52+$2.09$1.52$0.60M$0.02M
5/14/2024Q1 2024-$0.72-$0.84 -$0.12-$0.07$0.52M$0.01M
3/28/2024Q4 2023-$1.44-$0.72+$0.72-$0.06$2.17M$1.81M
11/9/2023Q3 2023-$1.20-$1.08+$0.12-$0.09$1.20M$1.00M
8/10/2023Q2 2023-$1.20-$1.20--$0.10--

Daré Bioscience Earnings - Frequently Asked Questions

Daré Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on DARE's earnings history.

In the previous quarter, Daré Bioscience (NASDAQ:DARE) reported ($0.50) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.63) by $0.13. Learn more on analysts' earnings estimate vs. DARE's actual earnings.

The conference call for Daré Bioscience's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Daré Bioscience's latest earnings report can be read online.
Read Transcript

Daré Bioscience (NASDAQ:DARE) has a recorded annual revenue of $25,909.00.

Daré Bioscience (NASDAQ:DARE) has a recorded net income of -$30.16 million. DARE has generated -$0.17 earnings per share over the last four quarters.

Daré Bioscience's earnings are expected to decrease from ($0.49) per share to ($1.90) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:DARE) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners